Amount | Holding |
---|---|
3.94% | Sarepta Therapeutics, Inc |
3.90% | Exelixis, Inc |
3.86% | Neurocrine Biosciences, Inc |
3.80% | Charles River Laboratories International, Inc |
3.79% | Bio-Techne Corporation |
3.66% | BioMarin Pharmaceutical Inc |
3.58% | Ultragenyx Pharmaceutical Inc |
3.55% | Alexion Pharmaceuticals, Inc |
3.53% | Exact Sciences Corporation |
3.52% | Seattle Genetics, Inc |